M
Mark L. Bassett
Researcher at University of Queensland
Publications - 20
Citations - 1071
Mark L. Bassett is an academic researcher from University of Queensland. The author has contributed to research in topics: Hemochromatosis & Serum iron. The author has an hindex of 11, co-authored 20 publications receiving 1033 citations. Previous affiliations of Mark L. Bassett include Canberra Hospital.
Papers
More filters
Journal ArticleDOI
Cohort Study of Internal Malignancy in Genetic Hemochromatosis and Other Chronic Nonalcoholic Liver Diseases
Robin A. Bradbear,Chris Bain,Victor Siskind,Francis D. Schofield,Sonja Webb,Elizabeth M. Axelsen,June W. Halliday,Mark L. Bassett,Lawrie W. Powell +8 more
TL;DR: The risk of hepatocellular carcinoma (HCC) and other internal malignancies was examined in patients with genetic hemochromatosis (GH) by comparing the numbers of cancers they developed with expected values constructed from cancer registry incidence data by means of actuarial methods.
Journal ArticleDOI
Screening for hemochromatosis in asymptomatic subjects with or without a family history
Lawrie W. Powell,Jeannette L. Dixon,Grant A. Ramm,David M. Purdie,Douglas J. Lincoln,Gregory J. Anderson,V. Nathan Subramaniam,David G. Hewett,Jeffrey Searle,Linda M. Fletcher,Darrell H. G. Crawford,Helen Rodgers,Katrina J. Allen,Juleen A. Cavanaugh,Mark L. Bassett +14 more
TL;DR: Screening for hemochromatosis in apparently healthy subjects homozygous for the C282Y mutation with or without a family history reveals comparable levels of hepatic iron overload and disease.
Journal ArticleDOI
Diagnosis of hemochromatosis in young subjects: Predictive accuracy of biochemical screening tests
TL;DR: It is concluded that the combination of serum ferritin and transferrin saturation is a reliable screening regimen for the detection of hemochromatosis and for predicting the level of body iron stores in young hemochROMatosis subjects.
Journal ArticleDOI
Hemochromatosis: 1980 update
Journal ArticleDOI
The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
Alissa Walsh,Jeannette L. Dixon,Grant A. Ramm,David G. Hewett,Douglas J. Lincoln,Gregory J. Anderson,V. Nathan Subramaniam,Julian Dodemaide,Juleen A. Cavanaugh,Mark L. Bassett,Lawrie W. Powell,Lawrie W. Powell +11 more
TL;DR: C282Y/H63D subjects referred for assessment had a high prevalence of increased iron indices but did not develop progressive clinical disease without comorbid factors such as steatosis, diabetes, or excess alcohol consumption.